AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
LACK OF IN-VIVO IN-VITRO CORRELATIONS FOR 50 MG AND 250 MG PRIMIDONE TABLETS
Authors: MEYER MC STRAUGHN AB MHATRE RM SHAH VP WILLIAMS RL LESKO LJ
Citation: Mc. Meyer et al., LACK OF IN-VIVO IN-VITRO CORRELATIONS FOR 50 MG AND 250 MG PRIMIDONE TABLETS, Pharmaceutical research, 15(7), 1998, pp. 1085-1089
IN-VITRO DISSOLUTION PROFILE COMPARISON - STATISTICS AND ANALYSIS OF THE SIMILARITY FACTOR, F(2)
Authors: SHAH VP TSONG Y SATHE P LIU JP
Citation: Vp. Shah et al., IN-VITRO DISSOLUTION PROFILE COMPARISON - STATISTICS AND ANALYSIS OF THE SIMILARITY FACTOR, F(2), Pharmaceutical research, 15(6), 1998, pp. 889-896
BIOEQUIVALENCE OF TOPICAL DERMATOLOGICAL DOSAGE FORMS - METHODS OF EVALUATION OF BIOEQUIVALENCE
Authors: SHAH VP FLYNN GL YACOBI A MAIBACH HI BON C FLEISCHER NM FRANZ TJ KAPLAN SA KAWAMOTO J LESKO LJ MARTY JP PERSHING LK SCHAEFER H SEQUEIRA JA SHRIVASTAVA SP WILKIN J WILLIAMS RL
Citation: Vp. Shah et al., BIOEQUIVALENCE OF TOPICAL DERMATOLOGICAL DOSAGE FORMS - METHODS OF EVALUATION OF BIOEQUIVALENCE, Pharmaceutical research, 15(2), 1998, pp. 167-171
THE RELATIVE BIOAVAILABILITY AND IN-VIVO IN-VITRO CORRELATIONS FOR 4 MARKETED CARBAMAZEPINE TABLETS
Authors: MEYER MC STRAUGHN AB MHATRE RM SHAH VP WILLIAMS RL LESKO LJ
Citation: Mc. Meyer et al., THE RELATIVE BIOAVAILABILITY AND IN-VIVO IN-VITRO CORRELATIONS FOR 4 MARKETED CARBAMAZEPINE TABLETS, Pharmaceutical research, 15(11), 1998, pp. 1787-1791
DISSOLUTION TESTING AS A PROGNOSTIC TOOL FOR ORAL-DRUG ABSORPTION - IMMEDIATE-RELEASE DOSAGE FORMS
Authors: DRESSMAN JB AMIDON GL REPPAS C SHAH VP
Citation: Jb. Dressman et al., DISSOLUTION TESTING AS A PROGNOSTIC TOOL FOR ORAL-DRUG ABSORPTION - IMMEDIATE-RELEASE DOSAGE FORMS, Pharmaceutical research, 15(1), 1998, pp. 11-22
ATP-CITRATE LYASE AS A TARGET FOR HYPOLIPIDEMIC INTERVENTION - 2 - SYNTHESIS AND EVALUATION OF -OMEGA-SUBSTITUTED-3-CARBOXY-3,5-DIHYDROXYALKANOIC ACIDS AND THEIR GAMMA-LACTONE PRODRUGS AS INHIBITORS OF THE ENZYME IN-VITRO AND IN-VIVO
Authors: GRIBBLE AD IFE RJ SHAW A MCNAIR D NOVELLI CE BAKEWELL S SHAH VP DOLLE RE GROOT PH PEARCE N YATES J TEW D BOYD H ASHMAN S EGGLESTON DS HALTIWANGER RC OKAFO G
Citation: Ad. Gribble et al., ATP-CITRATE LYASE AS A TARGET FOR HYPOLIPIDEMIC INTERVENTION - 2 - SYNTHESIS AND EVALUATION OF -OMEGA-SUBSTITUTED-3-CARBOXY-3,5-DIHYDROXYALKANOIC ACIDS AND THEIR GAMMA-LACTONE PRODRUGS AS INHIBITORS OF THE ENZYME IN-VITRO AND IN-VIVO, Journal of medicinal chemistry, 41(19), 1998, pp. 3582-3595
HUMAN INTESTINAL PERMEABILITY OF PIROXICAM, PROPRANOLOL, PHENYLALANINE, AND PEG-400 DETERMINED BY JEJUNAL PERFUSION
Authors: TAKAMATSU N WELAGE LS IDKAIDEK NM LIU DY LEE PID HAYASHI Y RHIE JK LENNERNAS H BARNETT JL SHAH VP LESKO L AMIDON GL
Citation: N. Takamatsu et al., HUMAN INTESTINAL PERMEABILITY OF PIROXICAM, PROPRANOLOL, PHENYLALANINE, AND PEG-400 DETERMINED BY JEJUNAL PERFUSION, Pharmaceutical research, 14(9), 1997, pp. 1127-1132
METHODS TO COMPARE DISSOLUTION PROFILES AND A RATIONALE FOR WIDE DISSOLUTION SPECIFICATIONS FOR METOPROLOL TARTRATE TABLETS
Authors: POLLI JE REKHI GS AUGSBURGER LL SHAH VP
Citation: Je. Polli et al., METHODS TO COMPARE DISSOLUTION PROFILES AND A RATIONALE FOR WIDE DISSOLUTION SPECIFICATIONS FOR METOPROLOL TARTRATE TABLETS, Journal of pharmaceutical sciences, 86(6), 1997, pp. 690-700
IN-VITRO DISSOLUTION PROFILE COMPARISON - STATISTICS AND ANALYSIS, MODEL DEPENDENT APPROACH
Authors: SATHE PM TSONG Y SHAH VP
Citation: Pm. Sathe et al., IN-VITRO DISSOLUTION PROFILE COMPARISON - STATISTICS AND ANALYSIS, MODEL DEPENDENT APPROACH, Pharmaceutical research, 13(12), 1996, pp. 1799-1803
EVALUATION OF ORALLY-ADMINISTERED HIGHLY VARIABLE DRUGS AND DRUG FORMULATIONS
Authors: SHAH VP YACOBI A BARR WH BENET LZ BREIMER D DOBRINSKA MR ENDRENYI L FAIRWEATHER W GILLESPIE W GONZALEZ MA HOOPER J JACKSON A LESKO LJ MIDHA KK NOONAN PK PATNAIK R WILLIAMS RL
Citation: Vp. Shah et al., EVALUATION OF ORALLY-ADMINISTERED HIGHLY VARIABLE DRUGS AND DRUG FORMULATIONS, Pharmaceutical research, 13(11), 1996, pp. 1590-1594
DRUG DISSOLUTION INTO MICELLAR SOLUTIONS - DEVELOPMENT OF A CONVECTIVE DIFFUSION-MODEL AND COMPARISON TO THE FILM EQUILIBRIUM-MODEL WITH APPLICATION TO SURFACTANT-FACILITATED DISSOLUTION OF CARBAMAZEPINE
Authors: CRISON JR SHAH VP SKELLY JP AMIDON GL
Citation: Jr. Crison et al., DRUG DISSOLUTION INTO MICELLAR SOLUTIONS - DEVELOPMENT OF A CONVECTIVE DIFFUSION-MODEL AND COMPARISON TO THE FILM EQUILIBRIUM-MODEL WITH APPLICATION TO SURFACTANT-FACILITATED DISSOLUTION OF CARBAMAZEPINE, Journal of pharmaceutical sciences, 85(9), 1996, pp. 1005-1011
ATP-CITRATE LYASE AS A TARGET FOR HYPOLIPIDEMIC INTERVENTION - DESIGNAND SYNTHESIS OF 2-SUBSTITUTED BUTANEDIOIC ACIDS AS NOVEL, POTENT INHIBITORS OF THE ENZYME
Authors: GRIBBLE AD DOLLE RE SHAW A MCNAIR D NOVELLI R NOVELLI CE SLINGSBY BP SHAH VP TEW D SAXTY BA ALLEN M GROOT PH PEARCE N YATES J
Citation: Ad. Gribble et al., ATP-CITRATE LYASE AS A TARGET FOR HYPOLIPIDEMIC INTERVENTION - DESIGNAND SYNTHESIS OF 2-SUBSTITUTED BUTANEDIOIC ACIDS AS NOVEL, POTENT INHIBITORS OF THE ENZYME, Journal of medicinal chemistry, 39(18), 1996, pp. 3569-3584
PHARMACODYNAMIC (PD) BIOEQUIVALENCE (BE) STUDIES ON BETAMETHASONE DIPROPIONATE CREAM (BPC)
Authors: SINGH GJP PIACQUADIO DJ PERSHING LK WILLICK K LAMBERT LD ADAMS WP SCHUIRMANN DJ SHRIVASTAVA S SHAH VP LESKO LJ WILLIAMS RL
Citation: Gjp. Singh et al., PHARMACODYNAMIC (PD) BIOEQUIVALENCE (BE) STUDIES ON BETAMETHASONE DIPROPIONATE CREAM (BPC), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 72-72
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY
Authors: AMIDON GL LENNERNAS H SHAH VP CRISON JR
Citation: Gl. Amidon et al., A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY, Pharmaceutical research, 12(3), 1995, pp. 413-420
IN-VITRO DISSOLUTION OF SPARINGLY WATER-SOLUBLE DRUG-DOSAGE FORMS
Authors: SHAH VP NOORY A NOORY C MCCULLOUGH B CLARKE S EVERETT R NAVIASKY H SRINIVASAN BN FORTMAN D SKELLY JP
Citation: Vp. Shah et al., IN-VITRO DISSOLUTION OF SPARINGLY WATER-SOLUBLE DRUG-DOSAGE FORMS, International journal of pharmaceutics, 125(1), 1995, pp. 99-106
IN-VITRO RELEASE FROM CORTICOSTEROID OINTMENTS
Authors: SHAH VP ELKINS JS
Citation: Vp. Shah et Js. Elkins, IN-VITRO RELEASE FROM CORTICOSTEROID OINTMENTS, Journal of pharmaceutical sciences, 84(9), 1995, pp. 1139-1140
PHARMACODYNAMIC (PD) MODELING TO DEVELOP BIOEQUIVALENCE (BE) METHODOLOGY FOR DERMATOLOGICAL CORTICOSTEROIDS (DCS)
Authors: SINGH GJP LESKO LJ SHAH VP ADAMS WP MOLZON JA WILLIAMS RL PERSHING LK
Citation: Gjp. Singh et al., PHARMACODYNAMIC (PD) MODELING TO DEVELOP BIOEQUIVALENCE (BE) METHODOLOGY FOR DERMATOLOGICAL CORTICOSTEROIDS (DCS), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 181-181
WORKSHOP-III REPORT - SCALEUP OF LIQUID AND SEMISOLID DISPERSE SYSTEMS
Authors: VANBUSKIRK GA SHAH VP ADAIR D ARBIT HM DIGHE SV FAWZI M FELDMAN T FLYNN GL GONZALEZ MA GRAY VA GUY RH HERD AK HEM SL HOIBERG C JERUSSI R KAPLAN AS LESKO LJ MALINOWSKI HJ MELTZER NM NEDICH RL PEARCE DM PECK G RUDMAN A SAVELLO D SCHWARTZ JB SCHWARTZ P SKELLY JP VANDERLAAN RK WANG JCT WEINER N WINKEL DR ZATZ JL
Citation: Ga. Vanbuskirk et al., WORKSHOP-III REPORT - SCALEUP OF LIQUID AND SEMISOLID DISPERSE SYSTEMS, Pharmaceutical research, 11(8), 1994, pp. 1216-1220
IN-VITRO DRUG-RELEASE MEASUREMENT FOR TOPICAL GLUCOCORTICOID CREAMS (VOL 19, PG 5048, 1993)
Authors: SHAH VP ELKINS JS WILLIAMS RL
Citation: Vp. Shah et al., IN-VITRO DRUG-RELEASE MEASUREMENT FOR TOPICAL GLUCOCORTICOID CREAMS (VOL 19, PG 5048, 1993), Pharmacopeial forum, 20(1), 1994, pp. 6961-6962
OPPORTUNITIES FOR INTEGRATION OF PHARMACOKINETICS, PHARMACODYNAMICS, AND TOXICOKINETICS IN RATIONAL DRUG DEVELOPMENT
Authors: PECK CC BARR WH BENET LZ COLLINS J DESJARDINS RE FURST DE HARTER JG LEVY G LUDDEN T RODMAN JH SANATHANAN L SCHENTAG JJ SHAH VP SHEINER LB SKELLY JP STANSKI DR TEMPLE RJ VISWANATHAN CT WEISSINGER J YACOBI A
Citation: Cc. Peck et al., OPPORTUNITIES FOR INTEGRATION OF PHARMACOKINETICS, PHARMACODYNAMICS, AND TOXICOKINETICS IN RATIONAL DRUG DEVELOPMENT, Journal of clinical pharmacology, 34(2), 1994, pp. 111-119
CROSS-LINKING OF GELATIN CAPSULES AND ITS RELEVANCE TO THEIR IN-VITROIN-VIVO PERFORMANCE
Authors: DIGENIS GA GOLD TB SHAH VP
Citation: Ga. Digenis et al., CROSS-LINKING OF GELATIN CAPSULES AND ITS RELEVANCE TO THEIR IN-VITROIN-VIVO PERFORMANCE, Journal of pharmaceutical sciences, 83(7), 1994, pp. 915-921
INSENSITIVITY OF DISSOLUTION TESTING FOR DIFFERENCES IN DIGOXIN BIOAVAILABILITY BIOEQUIVALENCE (BBE)/
Authors: SALE M BARBEY JT SHAH VP WILLIAMS RL WOOSLEY RL
Citation: M. Sale et al., INSENSITIVITY OF DISSOLUTION TESTING FOR DIFFERENCES IN DIGOXIN BIOAVAILABILITY BIOEQUIVALENCE (BBE)/, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 167-167
TOPICAL 0.050-PERCENT BETAMETHASONE DIPROPIONATE - PHARMACOKINETIC AND PHARMACODYNAMIC DOSE-RESPONSE STUDIES IN HUMANS
Authors: PERSHING LK LAMBERT L WRIGHT ED SHAH VP WILLIAMS RL
Citation: Lk. Pershing et al., TOPICAL 0.050-PERCENT BETAMETHASONE DIPROPIONATE - PHARMACOKINETIC AND PHARMACODYNAMIC DOSE-RESPONSE STUDIES IN HUMANS, Archives of dermatology, 130(6), 1994, pp. 740-747
PRINCIPLES AND CRITERIA IN THE DEVELOPMENT AND OPTIMIZATION OF TOPICAL THERAPEUTIC PRODUCTS
Authors: SHAH VP BEHL CR FLYNN GL HIGUCHI WI SCHAEFER H
Citation: Vp. Shah et al., PRINCIPLES AND CRITERIA IN THE DEVELOPMENT AND OPTIMIZATION OF TOPICAL THERAPEUTIC PRODUCTS, Skin pharmacology, 6(1), 1993, pp. 72-80
WORKSHOP-II REPORT - SCALE-UP OF ORAL EXTENDED-RELEASE DOSAGE FORMS
Authors: SKELLY JP VANBUSKIRK GA ARBIT HM AMIDON GL AUGSBURGER L BARR WH BERGE S CLEVENGER J DIGHE S FOX D GONZALEZ MA GRAY VA HOIBERG C JERUSSI R LEESON LJ LESKO L MALINOWSKI H NIXON PR PEARCE DM PECK G PORTER S ROBINSON J SAVELLO DR SCHWARTZ P SCHWARTZ JB SHAH VP THEEUWES F WHEATLEY T
Citation: Jp. Skelly et al., WORKSHOP-II REPORT - SCALE-UP OF ORAL EXTENDED-RELEASE DOSAGE FORMS, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 162-167
Risultati: 1-25 | 26-30